These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

941 related items for PubMed ID: 27550399

  • 21. Dabigatran, rivaroxaban and apixaban for extended venous thromboembolism treatment: network meta-analysis.
    Alotaibi G, Alsaleh K, Wu C, Mcmurtry MS.
    Int Angiol; 2014 Aug; 33(4):301-8. PubMed ID: 25056161
    [Abstract] [Full Text] [Related]

  • 22. Rivaroxaban and Apixaban for Initial Treatment of Acute Venous Thromboembolism of Atypical Location.
    Janczak DT, Mimier MK, McBane RD, Kamath PS, Simmons BS, Bott-Kitslaar DM, Lenz CJ, Vargas ER, Hodge DO, Wysokinski WE.
    Mayo Clin Proc; 2018 Jan; 93(1):40-47. PubMed ID: 29217335
    [Abstract] [Full Text] [Related]

  • 23. The use of direct oral anticoagulants in 56 patients with antiphospholipid syndrome.
    Malec K, Góralczyk T, Undas A.
    Thromb Res; 2017 Apr; 152():93-97. PubMed ID: 27989533
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Efficacy and safety of new oral anticoagulants for extended treatment of venous thromboembolism: systematic review and meta-analyses of randomized controlled trials.
    Sardar P, Chatterjee S, Mukherjee D.
    Drugs; 2013 Jul; 73(11):1171-82. PubMed ID: 23812923
    [Abstract] [Full Text] [Related]

  • 26. Effectiveness and Safety of Direct Oral Anticoagulants versus Warfarin in Obese Patients with Acute Venous Thromboembolism.
    Coons JC, Albert L, Bejjani A, Iasella CJ.
    Pharmacotherapy; 2020 Mar; 40(3):204-210. PubMed ID: 31968126
    [Abstract] [Full Text] [Related]

  • 27. Apixaban: A Review in Venous Thromboembolism.
    Greig SL, Garnock-Jones KP.
    Drugs; 2016 Oct; 76(15):1493-1504. PubMed ID: 27653758
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Comparative efficacy and safety of anticoagulants and aspirin for extended treatment of venous thromboembolism: A network meta-analysis.
    Sobieraj DM, Coleman CI, Pasupuleti V, Deshpande A, Kaw R, Hernandez AV.
    Thromb Res; 2015 May; 135(5):888-96. PubMed ID: 25795564
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Antidotes to non-vitamin K oral anticoagulants: necessary or not?
    Proietti M, Lip GY.
    Expert Opin Pharmacother; 2015 May; 16(11):1573-6. PubMed ID: 26077323
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Evaluation of anticoagulation selection for acute venous thromboembolism.
    Badreldin H, Nichols H, Rimsans J, Carter D.
    J Thromb Thrombolysis; 2017 Jan; 43(1):74-78. PubMed ID: 27592341
    [Abstract] [Full Text] [Related]

  • 38. Direct oral anticoagulants for extended treatment of venous thromboembolism: insights from the EINSTEIN CHOICE study.
    Imberti D, Pomero F, Mastroiacovo D.
    Blood Transfus; 2020 Jan; 18(1):49-57. PubMed ID: 31184579
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 48.